The antibody 34bE12, available from A Menarini Diagnostics, recognises cytokeratin 1, 5, 10 and 14. It reacts with squamous and adenosquamous cell carcinomas, while adenocarcinoma is negative. In normal tissue, 34bE12 stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchus. Thus, it is useful as a differential marker for squamous carcinoma and adenocarcinoma as well as for benign and malignant tumours of the prostate gland.
Other News
Latest Issues
Benson Viscometers is a world-leading manufacturer of clinical viscometers, trusted by hospitals, laboratories, universities and research institutions across the UK, USA, and Europe. Since 1999, they have provided reliable, high-precision clinical viscosity testing to support improved patient outcomes in conditions such as Multiple Myeloma,...
London GI Pathology Update 2026
Barbican Centre, London; and online.
28 April - 1 May
Specialist Staining – Technical Issues Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
28 April, 2026
Diagnostic Cytopathology – Beginners Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
5 May, 2026
Power to Disrupt : Leaders in POCT Diagnostics
Leonardo Royal Hotel, 245 Broad St, Birmingham, B1 2HQ
5 May, 2026
Diagnostic Cytopathology – Intermediate Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
6 May, 2026